<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041089</url>
  </required_header>
  <id_info>
    <org_study_id>18-AOI-02</org_study_id>
    <nct_id>NCT04041089</nct_id>
  </id_info>
  <brief_title>Development of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy</brief_title>
  <acronym>REEDUC-ACP</acronym>
  <official_title>Development and Evaluation of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy (PCA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the
      spatial location of objects, their manipulation and/or recognition. Its etiology is most
      often neurodegenerative, with a major impact on the autonomy and mood of patients and their
      families. Few studies have focused on non-medication management of these disorders.

      The present study thus has a double objective: the development of a complete tool to work on
      the recognition, localization and/or manipulation of objects; and the evaluation of the
      effectiveness of this type of management.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2, 2019</start_date>
  <completion_date type="Anticipated">September 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness evaluation</measure>
    <time_frame>At week 34</time_frame>
    <description>Effectiveness will be evaluated a score based on success rate (from 0 to 10), reaction time and eye-recording .</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Posterior Cortical Atrophy</condition>
  <arm_group>
    <arm_group_label>Recognition of objects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will do the therapy in the following order: object location, object manipulation and object recognition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Location of objects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will do the therapy in the following order: object recognition, object location, and object manipulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manipulation of objects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will do the therapy in the following order: object manipulation, object recognition and object location</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Recognition of objects</intervention_name>
    <description>Name of shapes / colors / images / objects
Classification of shapes / colors / images / objects</description>
    <arm_group_label>Recognition of objects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Location of objects</intervention_name>
    <description>Search for frequent/rarse targets among distractors sharing one or more characteristics with the target
Hit/catch a stationary/mobile target as quickly as possible</description>
    <arm_group_label>Location of objects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Manipulation of objects</intervention_name>
    <description>Storage of shapes/objects
Use of everyday objects (pen, cutlery, etc.)</description>
    <arm_group_label>Manipulation of objects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;50 years old

          -  Male or Female

          -  Patients with a diagnosis of PCA according to the criteria of Tang-Wai et al (2004)

          -  MMS&gt;15

          -  Voluntary, written and informed consent of the patient himself or its legal
             representative (guardian/curator), with oral consent of the patient in all cases

          -  Anti-Alzheimer's and psychotropic treatments stable for one month, if taken by the
             patient

          -  Affiliation to a social security system

        Exclusion Criteria:

          -  Uncorrected visual disorders with non-degenerative etiology (AV&lt;0.5)

          -  Person under the protection of justice

          -  Pregnant women (a pregnancy test will be performed in premenopausal women)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MOUTON Aurélie, Ph</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOUTON Aurélie, Ph</last_name>
    <phone>+33492034752</phone>
    <email>mouton.a2@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Claude Pompidou - Centre Mémoire de Ressources et de Recherche du CHU de Nice</name>
      <address>
        <city>Nice</city>
        <state>Alpes-Maritime</state>
        <zip>06100</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>MOUTON Aurélie, Ph</last_name>
      <phone>+334 92 03 47 52</phone>
      <email>mouton.a@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>MOUTON Aurélie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

